We are thrilled to announce the latest addition to our suite of transformative services at Bodify: Semaglutide for Weight Loss through Moon Valley Med Spa
Consulting actuaries in particular must balance long-term uncertainty with immediate forecasting needs
For GLP-1 RAs, projected QALY gain was 36,090 at a total healthcare cost increment of AU$2.9 billion, resulting in an ICER of AU$79,742 per QALY gained
Insurers in some markets are facing mounting market pressure to remove the exclusion on weight management to promote inclusivity, resulting in the imminent exposure of insurers in these markets to reimbursement of this class of drugs
Here are the key mechanisms: 1
Assess suppliers' formulation flexibility for incorporating additional actives, fragrance-free options, and vegan adaptations